japanja
Suit yourself! Exoskeletons: from science fiction to reality

Suit yourself! Exoskeletons: from science fiction to reality

07-11-2016 | リサーチ

Since the 1960s, engineers have been working on suits that enhance human strength. Over the years, these exterior skeletons, or exoskeletons, have improved hugely, clearing the way for a large number of use cases. For investors, it is key to identify the companies that will benefit from this trend and those that will lose out.

  • Jeroen van Oerle
    Jeroen
    van Oerle
    Portfolio Manager

Speed read

  • Exoskeletons can be applied in a wide range of industries
  • As competition is increasing rapidly, it’s difficult to pinpoint the winners
  • Losers are mainly found on the medical side, such as suppliers of wheelchairs and chiropractors

In the 1960s, the US Defense Department introduced their ‘man amplifier’, which would augment a soldier’s capacity to lift and carry heavy items. The exoskeleton was born. Initially, a human operator wore an exoskeleton following the master-slave principle. Every movement the human made was copied by the exoskeleton. This approach lacked practicality, mainly due to the bulky size required for strength and the lack of flexibility for the human operator. After years of development, the man-slave principle has been replaced by autonomous robotic systems that react to, but do not necessarily depend on, human movement. This clears the way for many use cases in the medical industry, elderly care, industrials and in the army.

最新の「インサイト」を読む
最新の「インサイト」を読む
配信登録

Medical applications

The medical exoskeleton market currently focuses on rehabilitation of spinal cord injury patients. This was a USD 45 million market in 2013, which is expected to grow to USD 2 billion by 2020. With exoskeletons, rehabilitation is much more efficient and quicker, which saves a lot of money. In addition, the upward position was proven to be superior to sitting in a wheelchair. Reduced pain and spasticity, improved bowel and urinary tract function, increased lean muscle mass, decreased fat and less dependence on medications are examples of direct benefits of standing up. We believe this technology is applicable to a much wider set of medical conditions and expect the number of users to grow substantially over the years, depending on regulatory approval.

Partial exoskeletons

Source:  AlterG

Elderly care

Exoskeletons can become a very important tool to keep elderly-care costs low. Exoskeletons allow elderly people to stay at home for a longer period of time and reduce the chance of mobility accidents. Most elderly people end up in nursing homes as a direct result of decreased mobility, not due to other decreasing skills to live independently. Still, current exoskeletons are too expensive and difficult to handle. Another important objection of elderly people is that exoskeletons look very lumpy. Developments of ‘soft-skeletons’ could be a solution. These increase muscle strength and are concealed under clothes.

The potential market for home mobility in the US concerns about 7.5 million people. This amounts to a USD 7.5bn market opportunity, assuming a conservative USD 10,000 cost per suit and a 10% adoption level. The cost reductions that can be realized through lower usage of elderly care facilities are substantial in developed countries. Japan is expected to be the first market for elderly care exoskeletons because of their fast increasing average age and state-of-the-art robot technology. We do not expect quick suit adoption in the near term. Once medical use cases have been proven, and the technology becomes more user friendly, we expect bigger appetite from this customer group.

Industrials

The medical exoskeleton market is dwarfed by the potential market size of industrial exoskeletons. In the industrials segment there is no regulator that needs to approve devices before they can be used, which increases adoption speed. Industrial exoskeletons augment strength, safety and endurance.

The US construction and manufacturing market consists of 13.5 million workers executing production and non-supervisory jobs. A large part of these jobs are repetitive and physically demanding. The annual costs related to back injury in the US construction industry are estimated at USD 50 billion. Industrial exoskeletons could reduce these costs substantially and improve productivity. Industrial exoskeletons could be a USD 19 billion market in the US by 2025, assuming suits will be applicable to 20% of industrial workers, at an average price of USD 7,100 per suit.

Army

In 2000, DARPA, a US defense agency, started to invest in exoskeleton research. In 2011, Lockheed Martin joined efforts by developing exoskeletons for army purposes in cooperation with robotics start-ups. Suits for the army are used to enable soldiers to walk long distances, climb steep mountains and carry heavy loads. They are also used for rescue missions after natural disasters. The military market is potentially large, and there are substantial entry barriers. It is difficult to determine the exact market size, also because many contracts  are initiated by governments that prefer secrecy.

Military exoskeleton

Source:  Science, 2015

Winners and losers

It is clear that robotics companies with exposure to this trend are expected to benefit. It is too early to determine winners though. First of all, competition is increasing very rapidly, thereby reducing economics quickly which makes it harder to invest in Research & Development. Secondly, well-established industrials are setting up units to develop suits and compete with pure-play start-ups. From an investment perspective, industrials are not pure-play enough and pure-plays are not yet mature enough to invest in.

In the industrial exoskeleton market, companies that use this new technology in their day-to-day business have a chance to outperform versus peers due to lower injury rates (and related costs) and increased productivity.

Exoskeleton technology does not compete with existing offerings in the military or in industrial use. Although one could argue that exoskeleton technology competes with automation providers, it is not unthinkable that both trends will develop alongside each other. On the medical side, this is not always the case. Suppliers of wheelchairs and walking aids may be impacted. Elderly care centers can also be affected if exoskeleton technology enables elderly people to live in their own homes for a longer period. Finally; chiropractors and other medical professions treating injuries related to heavy-physical labor might consider retraining into robotics engineers.

Leave your details and download the report

This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US citizens and residents.

重要事項

当資料は情報提供を目的として、Robeco Institutional Asset Management B.V.が作成した英文資料、もしくはその英文資料をロベコ・ジャパン株式会社が翻訳したものです。資料中の個別の金融商品の売買の勧誘や推奨等を目的とするものではありません。記載された情報は十分信頼できるものであると考えておりますが、その正確性、完全性を保証するものではありません。意見や見通しはあくまで作成日における弊社の判断に基づくものであり、今後予告なしに変更されることがあります。運用状況、市場動向、意見等は、過去の一時点あるいは過去の一定期間についてのものであり、過去の実績は将来の運用成果を保証または示唆するものではありません。また、記載された投資方針・戦略等は全ての投資家の皆様に適合するとは限りません。当資料は法律、税務、会計面での助言の提供を意図するものではありません。

ご契約に際しては、必要に応じ専門家にご相談の上、最終的なご判断はお客様ご自身でなさるようお願い致します。

運用を行う資産の評価額は、組入有価証券等の価格、金融市場の相場や金利等の変動、及び組入有価証券の発行体の財務状況による信用力等の影響を受けて変動します。また、外貨建資産に投資する場合は為替変動の影響も受けます。運用によって生じた損益は、全て投資家の皆様に帰属します。したがって投資元本や一定の運用成果が保証されているものではなく、投資元本を上回る損失を被ることがあります。弊社が行う金融商品取引業に係る手数料または報酬は、締結される契約の種類や契約資産額により異なるため、当資料において記載せず別途ご提示させて頂く場合があります。具体的な手数料または報酬の金額・計算方法につきましては弊社担当者へお問合せください。

当資料及び記載されている情報、商品に関する権利は弊社に帰属します。したがって、弊社の書面による同意なくしてその全部もしくは一部を複製またはその他の方法で配布することはご遠慮ください。

商号等: ロベコ・ジャパン株式会社  金融商品取引業者 関東財務局長(金商)第2780号

加入協会: 一般社団法人 日本投資顧問業協会

本記事に関連するテーマ: